Table 3.
Treatments and outcomes of patients with COVID-19.
| Items | All patients (n = 289) | Nonsevere (n = 197) | Severe (n = 92) | χ2 | P |
| Treatments | |||||
| Antiviral treatment | 253/264 (95.8) | 168/177 (94.9) | 85/87 (97.7) | – | 0.348 |
| Antibiotic treatment | 155/249 (62.2) | 120/178 (67.4) | 35/71 (49.3) | 7.091 | 0.008 |
| Antifungal treatment | 20/247 (8.1) | 4/173 (2.3) | 16/74 (21.6) | 25.969 | <0.001 |
| Noninvasive ventilation | 62/270 (23.0) | 0 (0) | 62/89 (69.7) | ||
| Invasive ventilation | 6/270 (2.2) | 0 (0) | 6/89 (6.7) | ||
| Renal replacement therapy | 4/270 (1.5) | 0 (0) | 4/89 (4.5) | ||
| Inotropes/vasopressors | 4/270 (1.5) | 0 (0) | 4/89 (4.5) | ||
| Neuromuscular blocking agents | 4/270 (1.5) | 0 (0) | 4/89 (4.5) | ||
| ECMO | 2/270 (0.7) | 0 (0) | 2/89 (2.2) | ||
| Outcomes | – | 0.002 | |||
| Discharged alive | 154/218 (70.6) | 112/148 (75.7) | 42/70 (60.0) | ||
| Hospitalization | 51/218 (23.4) | 30/148 (20.3) | 21/70 (30.0) | ||
| Transfer to other facility | 8/218 (3.7) | 6/148 (4.1) | 2/70 (2.9) | ||
| Death | 5/218 (2.3) | 0/148 (0) | 5/70 (7.1) | ||
Data are presented as n/N (%). COVID-19: Coronavirus disease 2019; ECMO: Extracorporeal membrane oxygenation; –: Not applicable.